If you would like additional information regarding AstraZeneca's products, please contact the Information Center at AstraZeneca in the U.S. at 1-800-236-9933, Monday through Friday 8am - 7pm ET, excluding holidays.
PULMICORT RESPULES is developed and approved specifically for children 12 months to 8 years of age, to help prevent asthma symptoms that could lead to an attack. PULMICORT RESPULES, an inhaled corticosteroid, is not a quick-relief medication and should NOT be used to treat an acute (sudden) asthma attack.
Important Safety Information you should know
PULMICORT RESPULES, an inhaled corticosteroid, is not a quick-relief medication and should NOT be used to treat an acute asthma attack. In studies, side effects included respiratory infection, runny nose, earache, and coughing. Inhaled corticosteroids may cause a reduction in growth rate. The long-term effect on final adult height is unknown. If switching to PULMICORT RESPULES from an oral (syrup or pill) corticosteroid, follow the doctor's instructions to help avoid health risks. Tell the doctor if your child is exposed to chicken pox or measles.
Click here for full Prescribing Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.
This product information is intended for US consumers only.
PULMICORT RESPULES is a registered trademark and ASTHMAKIDCARE and EVERYDAYKIDZ are trademarks of the AstraZeneca group of companies.
Copyright ©2008 AstraZeneca LP. All rights reserved. 262111 4/08